Matthew Cohen - Stem Holdings President, CoFounder

STMH Stock

USD 0.01 0.00 0.00%

Insider

Matthew Cohen is President, CoFounder of Stem Holdings

Age	65
Phone	561 948 5410
Web	https://stemholdings.com

Matthew Cohen Latest Insider Activity

Tracking and analyzing the buying and selling activities of Matthew Cohen against Stem Holdings otc stock is an integral part of due diligence when investing in Stem Holdings. Matthew Cohen insider activity provides valuable insight into whether Stem Holdings is net buyers or sellers over its current business cycle. Note, Stem Holdings insiders must abide by specific rules, including filing SEC forms every time they buy or sell Stem Holdings'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Matthew Cohen over a year ago

Payment of 90146 shares by Matthew Cohen of Flora Growth subject to Rule 16b-3

Stem Holdings Management Efficiency

The company has return on total asset (ROA) of (0.1752) % which means that it has lost $0.1752 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6482) %, meaning that it created substantial loss on money invested by shareholders. Stem Holdings' management efficiency ratios could be used to measure how well Stem Holdings manages its routine affairs as well as how well it operates its assets and liabilities.

Compare Stem Holdings to Peers

Predict price of Stem Holdings

Stem Holdings currently holds 1.23 M in liabilities with Debt to Equity (D/E) ratio of 0.44, which is about average as compared to similar companies. Stem Holdings has a current ratio of 1.23, suggesting that it may have difficulties to pay its financial obligations when due. Debt can assist Stem Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, Stem Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Stem Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Stem to invest in growth at high rates of return. When we think about Stem Holdings' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives			INSIDER Age
	Marlo Manning	Collegium Pharmaceutical	N/A
	Jeff Holm	Biofrontera	N/A
	BComm BCom	Akanda Corp	68
	OriMoni Mimon	INC Research Holdings	36
	Thomas Flow	Akanda Corp	46
	Raymond Coffman	cbdMD Inc	62
	Advocate Ohayon	INC Research Holdings	35
	Tejinder Virk	Akanda Corp	42
	Mark Baldyga	Biofrontera	N/A
	Muthusamy RPh	ANI Pharmaceuticals	56
	Elizabeth JD	ANI Pharmaceuticals	N/A
	CCFP DipSportMed	Evolus Inc	60
	David Erickson	Evolus Inc	N/A
	Erica CPA	Biofrontera	39
	Hermann Lubbert	Biofrontera	68
	Rami Levy	INC Research Holdings	59
	Amos Cohen	INC Research Holdings	45
	Matthew Coapman	cbdMD Inc	48
	Scott Sudduth	Collegium Pharmaceutical	N/A
	Eugene III	Biofrontera	39
	John Weston	cbdMD Inc	N/A

Stem Holdings, Inc. operates as a vertically-integrated cannabis products and technology company. The company was incorporated in 2016 and is headquartered in Boca Raton, Florida. Stem Holdings operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 450 people. Stem Holdings [STMH] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

	Return On Equity	-0.65
	Return On Asset	-0.18

Stem Holdings Leadership Team

Elected by the shareholders, the Stem Holdings' board of directors comprises two types of representatives: Stem Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Stem. The board's role is to monitor Stem Holdings' management team and ensure that shareholders' interests are well served. Stem Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Stem Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.

	Robert Esq, Sec Counsel
	Matthew Cohen, President, CoFounder
	Steven Hubbard, CoFounder Director
	Mauria Betts, Director PR

Stem Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Stem Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

	Return On Equity	-0.65
	Return On Asset	-0.18
	Profit Margin	(1.05) %
	Operating Margin	(0.75) %
	Current Valuation	13.19 M
	Shares Outstanding	238.5 M
	Shares Owned By Insiders	1.84 %
	Shares Owned By Institutions	0.12 %
	Price To Book	0.18 X
	Price To Sales	0.14 X

Currently Active Assets on Macroaxis

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C
MSFT	Microsoft
GM	General Motors

Other Information on Investing in Stem OTC Stock

Stem Holdings financial ratios help investors to determine whether Stem OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Stem with respect to the benefits of owning Stem Holdings security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC